In a first of its kind study, researchers have discovered the conditions by which specific signals in primary tumors of head and neck and breast cancers, pre-program cancer cells to become dormant and evade chemotherapy after spreading. Their findings could lead to new drug development, treatment options and transform the way doctors care for cancer patients to treat metastatic disease.